Graf Akcie NBRV (Nabriva Therapeutics Plc). Diskuze k akciím NBRV. Aktuální informace NBRV.

Základní informace o společnosti Nabriva Therapeutics Plc (Akcie NBRV)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 58.3M
Hodnota podniku (EV) N/A
Tržby 14.523M
EBITDA N/A
Zisk -56.52
Růst v tržbách Q/Q 1,592.61 %
Růst v tržbách Y/Y 70.28 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.02
EV/Sales 0.07
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 4.01
P/FCF N/A
Price/Book 1.76
Účetní hodnota na akcii 0.67
Hotovost na akcii 0.84
FCF vůči ceně -113.55 %
Počet zaměstnanců 72
Tržba na zaměstnance 201.708k
Profit margin -1,382.22 %
Operating margin -387.76 %
Gross margin 84.76 %
EBIT margin -378.24 %
EBITDA margin -2,714.45 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -79.29 %
EPS - Očekávaný růst příští rok -75.56 %
Return on assets -77.95 %
Return on equity -116.80 %
ROIC -88.64 %
ROCE -72.09 %
Dluhy/Equity 0.76
Čistý dluh/EBITDA 1.89
Current ratio 4.93
Quick Ratio 4.40
Volatilita 4.40
Beta 1.21
RSI 55.96
Cílová cena analytiků 2
Známka akcie (dle analytiků) 2.60
Insider ownership 1.14 %
Institutional ownership 8.64 %
Počet akcií 49.739M
Procento shortovaných akcií 2.91 %
Short ratio 1.93 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země Ireland

Finanční výsledky akcie NBRV

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$9.481$9.656$5.319$6.482$3.767$2.398
Cost Of Goods Sold$0.07-----
Gross Profit$9.411$9.656$5.319$6.482$3.767$2.398
Research And Development Expenses$26.415$82.288$49.615$47.994$23.604$9.355
SG&A Expenses$62.485$41.743$29.472$13.535$7.921$3.739
Other Operating Income Or Expenses---$-0.783$2.427$-0.524
Operating Expenses$88.97$124.031$79.087$62.312$29.098$13.618
Operating Income$-79.489$-114.375$-73.768$-55.83$-25.331$-11.22
Total Non-Operating Income/Expense$-3.174$-0.356$0.767$0.268$-22.078$-2.908
Pre-Tax Income$-82.663$-114.731$-73.001$-55.562$-47.409$-14.128
Income Taxes$0.101$0.049$1.355$-0.672$-0.445$0.094
Income After Taxes$-82.764$-114.78$-74.356$-54.89$-46.964$-14.222
Other Income------
Income From Continuous Operations$-82.764$-114.78$-74.356$-54.89$-46.964$-14.222
Income From Discontinued Operations------
Net Income$-82.764$-114.78$-74.356$-54.89$-46.964$-14.222
EBITDA$-78.719$-113.865$-73.336$-55.597$-25.178$-11.054
EBIT$-79.489$-114.375$-73.768$-55.83$-25.331$-11.22
Basic Shares Outstanding7451302110
Shares Outstanding7451302110
Basic EPS$-1.12$-2.26$-2.49$-2.56$-48.03$-44.39
EPS - Earnings Per Share$-1.12$-2.26$-2.49$-2.56$-48.03$-44.39
# 2020 2019 2018 2017 2016 2015
Current Ratio5.47936.10777.07685.707713.03050.1147
Long-term Debt / Capital0.45530.25680.0028---0.1037
Debt/Equity Ratio0.83590.34560.0028---0.7311
Gross Margin99.2617100100100100100
Operating Margin-838.4031-1184.497-1386.877-861.3083-672.4449-467.8899
EBIT Margin-838.4031-1184.497-1386.877-861.3083-672.4449-467.8899
EBITDA Margin-830.2816-1179.215-1378.756-857.7137-668.3833-460.9674
Pre-Tax Profit Margin-871.8806-1188.183-1372.457-857.1737-1258.535-589.1577
Net Profit Margin-872.9459-1188.691-1397.932-846.8065-1246.722-593.0776
Asset Turnover0.10070.08740.05550.06950.0320.4552
Inventory Turnover Ratio0.1026-----
Receiveable Turnover3.45522.49440.98461.16560.8981.1691
Days Sales In Receivables105.6386146.3251370.6956313.1387406.4707312.1998
ROE - Return On Equity-200.5233-167.2446-90.6029-71.0495-43.202835.4749
Return On Tangible Equity-200.9664-167.4838-90.7932-71.2987-43.20435.4631
ROA - Return On Assets-87.9411-103.9505-77.6459-58.8696-39.8977-269.9688
ROI - Return On Investment-109.2219-124.2907-90.3475-71.0495-43.202839.1541
Book Value Per Share0.43661.0242.235728.402951.423-123.4678
Operating Cash Flow Per Share0.46280.893-0.074918.409914.4388-35.0985
Free Cash Flow Per Share0.46650.9278-0.086218.586114.5023-35.3662